No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
WST250117P480000
- 0.00
- 0.000.00%
15min DelayClose Jan 10 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest480.00Strike Price0.00Turnover0.00%IV-44.70%PremiumJan 17, 2025Expiry Date148.27Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.24Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
West Pharmaceutical Servs Analyst Ratings
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet
Citi Initiates West Pharmaceutical Services(WST.US) With Buy Rating, Announces Target Price $400
Promising Growth and Profitability Drive Buy Rating for West Pharmaceutical Services
Citigroup Initiates West Pharmaceutical Services at Buy With $400 Price Target
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference